Name | Cdk2/Cyclin Inhibitory Peptide I |
---|
Description | Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1]. |
---|---|
Related Catalog | |
Target |
CDK2[1]. |
In Vitro | Cdk2/Cyclin Inhibitory Peptide I (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: U2OS osteosarcoma cells Concentration: 0-150 µM Incubation Time: 24 h Result: Exhibited good activity to kill U2OS osteosarcoma cells. |
Molecular Formula | C111H196N48O23 |
---|---|
Molecular Weight | 2571.05 |